Terms: = Lung cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Treatment
33 results:
1. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer.
Lee JY; Bhandare RR; Boddu SHS; Shaik AB; Saktivel LP; Gupta G; Negi P; Barakat M; Singh SK; Dua K; Chellappan DK
Biomed Pharmacother; 2024 Apr; 173():116275. PubMed ID: 38394846
[TBL] [Abstract] [Full Text] [Related]
2. Anemoside B4 prevents chronic obstructive pulmonary disease through alleviating cigarette smoke-induced inflammatory response and airway epithelial hyperplasia.
Ma H; Zhou Z; Chen L; Wang L; Muge Q
Phytomedicine; 2022 Dec; 107():154431. PubMed ID: 36115169
[TBL] [Abstract] [Full Text] [Related]
3. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract] [Full Text] [Related]
4. Recent advances in small cell lung cancer: the future is now?
Luciani A; Blasi M; Provenzano L; Zonato S; Ferrari D
Minerva Endocrinol (Torino); 2022 Dec; 47(4):460-474. PubMed ID: 33331739
[TBL] [Abstract] [Full Text] [Related]
5. fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells.
Druck T; Cheung DG; Park D; Trapasso F; Pichiorri F; Gaspari M; Palumbo T; Aqeilan RI; Gaudio E; Okumura H; Iuliano R; Raso C; Green K; Huebner K; Croce CM
Cell Death Dis; 2019 Feb; 10(3):147. PubMed ID: 30770797
[TBL] [Abstract] [Full Text] [Related]
6. Exome-wide single-base substitutions in tissues and derived cell lines of the constitutive fhit knockout mouse.
Paisie CA; Schrock MS; Karras JR; Zhang J; Miuma S; Ouda IM; Waters CE; Saldivar JC; Druck T; Huebner K
Cancer Sci; 2016 Apr; 107(4):528-35. PubMed ID: 26782170
[TBL] [Abstract] [Full Text] [Related]
7. Fragile histidine triad (fhit) suppresses proliferation and promotes apoptosis in cholangiocarcinoma cells by blocking PI3K-Akt pathway.
Huang Q; Liu Z; Xie F; Liu C; Shao F; Zhu CL; Hu S
ScientificWorldJournal; 2014; 2014():179698. PubMed ID: 24757411
[TBL] [Abstract] [Full Text] [Related]
8. Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.
Samakoglu S; Deevi DS; Li H; Wang S; Murphy M; Bao C; Bassi R; Prewett M; Tonra JR
Cancer Genomics Proteomics; 2012; 9(2):77-92. PubMed ID: 22399498
[TBL] [Abstract] [Full Text] [Related]
9. Enzastaurin inhibits invasion and metastasis in lung cancer by diverse molecules.
Körner A; Mudduluru G; Manegold C; Allgayer H
Br J Cancer; 2010 Sep; 103(6):802-11. PubMed ID: 20736951
[TBL] [Abstract] [Full Text] [Related]
10. CpG island methylator phenotype involving chromosome 3p confers an increased risk of non-small cell lung cancer.
Liu Z; Li W; Lei Z; Zhao J; Chen XF; Liu R; Peng X; Wu ZH; Chen J; Liu H; Zhou QH; Zhang HT
J Thorac Oncol; 2010 Jun; 5(6):790-7. PubMed ID: 20521346
[TBL] [Abstract] [Full Text] [Related]
11. Transanal endoscopic microsurgery for rectal tumors: experience at Korea's National cancer Center.
Jeong WK; Park JW; Choi HS; Chang HJ; Jeong SY
Surg Endosc; 2009 Nov; 23(11):2575-9. PubMed ID: 19347399
[TBL] [Abstract] [Full Text] [Related]
12. fhit and p53 status and response to platinum-based treatment in advanced non-small cell lung cancer.
Cortinovis DL; Andriani F; Livio A; Fabbri A; Perrone F; Marcomini B; Pilotti S; Mariani L; Bidoli P; Bajetta E; Roz L; Sozzi G
Curr Cancer Drug Targets; 2008 Aug; 8(5):342-8. PubMed ID: 18690840
[TBL] [Abstract] [Full Text] [Related]
13. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
Fabbri M; Garzon R; Cimmino A; Liu Z; Zanesi N; Callegari E; Liu S; Alder H; Costinean S; Fernandez-Cymering C; Volinia S; Guler G; Morrison CD; Chan KK; Marcucci G; Calin GA; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15805-10. PubMed ID: 17890317
[TBL] [Abstract] [Full Text] [Related]
14. [Loss of exons of fhit gene and fhit protein expression in Yunnan tin miners with lung cancer].
Ruan YH; Gao Q; Zhang L; Hua HR; Cheng JL; Jin KW
Ai Zheng; 2007 Jun; 26(6):607-12. PubMed ID: 17562266
[TBL] [Abstract] [Full Text] [Related]
15. Induction of apoptosis by tumor suppressor fhit via death receptor signaling pathway in human lung cancer cells.
Deng WG; Nishizaki M; Fang B; Roth JA; Ji L
Biochem Biophys Res Commun; 2007 Apr; 355(4):993-9. PubMed ID: 17328863
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicity.
Cantor JP; Iliopoulos D; Rao AS; Druck T; Semba S; Han SY; McCorkell KA; Lakshman TV; Collins JE; Wachsberger P; Friedberg JS; Huebner K
Int J Cancer; 2007 Jan; 120(1):24-31. PubMed ID: 17019711
[TBL] [Abstract] [Full Text] [Related]
17. Protein expression profiling identifies cyclophilin A as a molecular target in fhit-mediated tumor suppression.
Semba S; Huebner K
Mol Cancer Res; 2006 Aug; 4(8):529-38. PubMed ID: 16885564
[TBL] [Abstract] [Full Text] [Related]
18. Cohypermethylation of p16 and fhit promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
Kim JS; Kim JW; Han J; Shim YM; Park J; Kim DH
Cancer Res; 2006 Apr; 66(8):4049-54. PubMed ID: 16618724
[TBL] [Abstract] [Full Text] [Related]
19. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract] [Full Text] [Related]
20. Increased sensitivity to cisplatin in non-small cell lung cancer cell lines after fhit gene transfer.
Andriani F; Perego P; Carenini N; Sozzi G; Roz L
Neoplasia; 2006 Jan; 8(1):9-17. PubMed ID: 16533421
[TBL] [Abstract] [Full Text] [Related]
[Next]